Coronavirus Mortality Study in Sweden Is Consistent with US Study
By Joe Hoft
Confirms Overall Mortality Not Much Different Than a Bad Seasonal Flu
On March 17, 2020, we were the first to identify that the WHO and the WHO’s Director General Tedros were pushing fraudulent numbers regarding the expected mortality of the coronavirus. The WHO grossly over-stated the mortality rate of the virus.
We then followed up with multiple posts on the subject. Next we reported on June 7, 2020, a study showed that when looking at the mortality rates for all causes this flu season, things aren’t much worse than a bad flu.
Then we reviewed the data in the US and found that this data supported our observation that the original coronavirus numbers were grossly overstated.
On June 18, 2020, Dr. Richard Cross, PhD, provided us the following information related to the China coronavirus in the United States. We were given his permission to share sections of his report:
When it comes to the COVID-19 event, we have been experiencing a serious case of tunnel vision. As we focus on the day to day increase of COVID-19 things could look pretty grim, but as we take a step back and look at the comparative total mortality here in the US, things aren’t much worse than a bad seasonal flu, like that last seen in 2017-18. If you take the New York City region out of the mix, the rest of the country is cumulatively well within the expected mortality.
The estimated death toll from COVID-19 is on track to exceed 120,000 US deaths in the next few weeks. Yet, the majority of COVID-19 related deaths have been concentrated in the New York/New England region which to date includes nearly 50 percent of all COVID-19 deaths nationwide; the hospitals in this region were strained but not overwhelmed in the middle of April. The coronavirus’ effect on New York City has been especially telling if you examine the departure from expected cumulative mortality trends over the last four years in the CDC fluseason cycle.
We avoid looking at the COVID-19 counts, and rather focus on total mortality (by all causes) since this perspective avoids the diagnostic uncertainty of determining the exact cause of death, and does not rely on sampling problems associated with COVID-19 testing or potentially inflated death estimates from the virus.